Osteoporosis Market to Register Incremental Growth During the Forecast Period 2030, Asserts DelveInsight | Key Companies – Amgen, Pfizer, Roche, Novartis, Pfenex, Haoma Medica, Eli Lilly, and Others

 Breaking News
  • No posts were found

Osteoporosis Market to Register Incremental Growth During the Forecast Period 2030, Asserts DelveInsight | Key Companies – Amgen, Pfizer, Roche, Novartis, Pfenex, Haoma Medica, Eli Lilly, and Others

December 13
19:03 2021
Osteoporosis Market to Register Incremental Growth During the Forecast Period 2030, Asserts DelveInsight | Key Companies - Amgen, Pfizer, Roche, Novartis, Pfenex, Haoma Medica, Eli Lilly, and Others
Delveinsight Business Research LLP
DelveInsight’s “Osteoporosis Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Osteoporosis Market Size and Share in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Osteoporosis market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2017 to 2030. It evaluates the current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Osteoporosis Market

Osteoporosis: An Overview

Osteoporosis is defined as a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture. This well-established definition, developed by the international consensus in 1993, captures two important characteristics of the disease: its adverse effects on bone mass and microstructure, and the clinical outcome of fracture.

Osteoporosis Market Key Facts

  • The United States accounts for the largest market size of Osteoporosis, in comparison to EU5 (the United Kingdom, Germany, Italy, France, and Spain) and Japan.

  • The total diagnosed prevalent population of osteoporosis in the seven major markets was found to be 28,097,783 cases in 2017. The total diagnosed prevalent population of Osteoporosis in the United States was found to be 6,380,754 cases in 2017, which is expected to increase by 2030.

  • In the EU5 countries, the total diagnosed prevalent population of Osteoporosis was found to be maximum in Germany with 4,309,667 cases, followed by Italy with 3,840,703 cases in 2017. France had the lowest number of diagnosed prevalent cases of osteoporosis with 2,786,944 cases in 2017.

  • Japan accounted for 4,513,275 cases of diagnosed prevalent osteoporosis in 2017, which is expected to increase in the forecast period 2020–2030.

  • Around the world, 1 in 3 women and 1 in 5 men aged fifty years and over are at risk of an osteoporotic fracture. In fact, an osteoporotic fracture is estimated to occur every 3 seconds.

  • As per Delveinsight, up to 30% of patients suffering from a hip fracture will require long-term nursing-home care.

Osteoporosis Market

The market size of Osteoporosis in the seven major markets was 9,442.73 USD Million in 2017, which will increase by 2030. Osteoporosis market size is expected to increase during the forecast owing to the rise in the number of prevalent cases in the 7MM.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Osteoporosis market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Osteoporosis market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Get FREE sample copy at: Osteoporosis Therapeutics Market

Osteoporosis Epidemiology

The epidemiology section covers insights about the historical and current Osteoporosis patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Osteoporosis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Osteoporosis market or expected to get launched in the market during the study period. The analysis covers Osteoporosis market uptake by drugs; patient uptake by therapies; and sales of each drug. 

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Osteoporosis Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

Osteoporosis Therapeutics Analysis

The current market is already dominated by biosimilars and generics, which are quite promising and have the potential for the treatment of osteoporosis. However the pipeline for Osteoporosis does not hold significant products, it has few products, which are being developed by certain key players.

Key companies in the Osteoporosis Market include:

  • Amgen

  • Haoma Medica

  • Pfizer

  • Radius Health

  • TherapeuticsMD

  • Roche

  • Novartis Pharmaceuticals

  • Eli Lilly

  • Pfenex

And many others.

Osteoporosis therapies covered in the report include:

  • Alendronate/Zoledronic Acid

  • NaQuinate

  • Evenity (Romosozumab-aqqg)

  • Prolia (Denosumab)

  • Fablyn (Lasofoxifene)

  • Duavee (conjugated estrogens/bazedoxifene)

  • Tymlos (abaloparatide)

  • Bijuva (estradiol and progesterone)

  • Boniva (ibandronate sodium)

  • Bonsity (PF708)

And many more.

The pipeline of osteoporosis marks a significant unmet need due to the availability of few products. There is a need for developing new drugs in the pipeline so that the emerging market of osteoporosis can prosper as well.

Request for Sample @ Osteoporosis Emerging Therapies and Key Companies

Table of Content

1. Key Insights

2. Executive Summary 

3. Osteoporosis Competitive Intelligence Analysis

4. Osteoporosis Market Overview at a Glance

5. Osteoporosis Disease Background and Overview

6. Osteoporosis Patient Journey

7. Osteoporosis Epidemiology and Patient Population

8. Osteoporosis Treatment Algorithm, Current Treatment, and Medical Practices

9. Osteoporosis Unmet Needs

10. Key Endpoints of Osteoporosis Treatment

11. Osteoporosis Marketed Products

12. Osteoporosis Emerging Therapies

13. Osteoporosis Seven Major Market Analysis

14. Attribute Analysis

15. Osteoporosis Market Outlook (7 major markets)

16. Osteoporosis Access and Reimbursement Overview

17. KOL Views on the Osteoporosis Market.

18. Osteoporosis Market Drivers

19. Osteoporosis Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at: https://www.delveinsight.com/sample-request/osteoporosis-market

Latest Report By DelveInsight

Down Syndrome Market

DelveInsight’s “Down Syndrome Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Down Syndrome market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Related Articles

Calendar

January 2022
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Categories